Batista-Duharte, A.; Hassouneh, F.; Alvarez-Heredia, P.; Pera, A.; Solana, R.
Immune Checkpoint Inhibitors for Vaccine Improvements: Current Status and New Approaches. Pharmaceutics 2022, 14, 1721.
https://doi.org/10.3390/pharmaceutics14081721
AMA Style
Batista-Duharte A, Hassouneh F, Alvarez-Heredia P, Pera A, Solana R.
Immune Checkpoint Inhibitors for Vaccine Improvements: Current Status and New Approaches. Pharmaceutics. 2022; 14(8):1721.
https://doi.org/10.3390/pharmaceutics14081721
Chicago/Turabian Style
Batista-Duharte, Alexander, Fakhri Hassouneh, Pablo Alvarez-Heredia, Alejandra Pera, and Rafael Solana.
2022. "Immune Checkpoint Inhibitors for Vaccine Improvements: Current Status and New Approaches" Pharmaceutics 14, no. 8: 1721.
https://doi.org/10.3390/pharmaceutics14081721
APA Style
Batista-Duharte, A., Hassouneh, F., Alvarez-Heredia, P., Pera, A., & Solana, R.
(2022). Immune Checkpoint Inhibitors for Vaccine Improvements: Current Status and New Approaches. Pharmaceutics, 14(8), 1721.
https://doi.org/10.3390/pharmaceutics14081721